Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.

In a move aimed at reducing antibiotic resistance, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that four of the most widely prescribed antibiotics...

In this monthly series, Australian Pharmacist speaks to the experts to answer some of your most frequently asked questions.

The new federal government last night delivered its 2022–23 ‘bread and butter’ Budget amid a growing cost-of-living crisis.

PSA's new President, Professor Mark Naunton MPS, was unanimously elected by the Board to serve as the next president from January 2026.

Pharmacists are on the verge of a major acceleration in their scope of practice, but a shift in perspective is needed first, delegates heard...